Fig. 1
From: Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine
The potential of fecal microbiota transplantation (FMT) precision medicine for gastrointestinal disorders. Left panel: candidates for FMT should be selected on clinical, microbial, immune, and metabolic parameters. Middle panel: FMT design should be tailored to each patient and include the type and timing of the FMT procedure, the criteria for the donor selection, and the potential use of adjuvant therapy. Right panel: patients should be monitored after FMT to determine effectiveness, gauge immune, and microbiome parameters and adjust the therapeutic strategy accordingly. SCFA, short-chain fatty acid